Literature DB >> 10425226

Heat shock protein 27 plays two distinct roles in controlling human breast cancer cell migration on laminin-5.

W Rust1, K Kingsley, T Petnicki, S Padmanabhan, S W Carper, G E Plopper.   

Abstract

It has recently been reported that phosphorylation of the small heat shock protein 27 (hsp27) enhances p38 MAP kinase dependent migration of bovine and human vascular endothelial cells. We have examined the role of hsp27 in controlling the constitutive migration of human breast cancer cells on the extracellular matrix molecule laminin-5. In a haptotaxis assay, anisomycin- or heat shock-induced phosphorylation of hsp27 enhances migration of MDA-MB-231 breast cancer cells constitutively overexpressing hsp27. Under these conditions, hsp27 redistributes to the nucleus. Unphosphorylated hsp27, which remains in the cytosol, induces resistance to a subset of drugs that inhibit haptotactic migration of these cells. We conclude that hsp27 plays two distinct roles in controlling migration of breast cancer cells: phosphorylated hsp27 enhances migration, while unphosphorylated hsp27 can sustain migration in the presence of inhibitory drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425226     DOI: 10.1006/mcbr.1999.0130

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  10 in total

1.  Hsp-27 induction requires POU4F2/Brn-3b TF in doxorubicin-treated breast cancer cells, whereas phosphorylation alters its cellular localisation following drug treatment.

Authors:  Rieko Fujita; Samir Ounzain; Alice Chun Yin Wang; Richard John Heads; Vishwanie Shanie Budhram-Mahadeo
Journal:  Cell Stress Chaperones       Date:  2011-01-29       Impact factor: 3.667

2.  Expression and distribution of HSP27 in response to G418 in different human breast cancer cell lines.

Authors:  Lu Qian; Zhiyi Zhang; Ming Shi; Ming Yu; Meiru Hu; Qing Xia; Beifen Shen; Ning Guo
Journal:  Histochem Cell Biol       Date:  2006-05-30       Impact factor: 4.304

3.  Silencing Hsp25/Hsp27 gene expression augments proteasome activity and increases CD8+ T-cell-mediated tumor killing and memory responses.

Authors:  Ganachari M Nagaraja; Punit Kaur; William Neumann; Edwina E Asea; María A Bausero; Gabriele Multhoff; Alexzander Asea
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-20

Review 4.  Heat shock proteins in animal neoplasms and human tumours--a comparison.

Authors:  Mariarita Romanucci; Tania Bastow; Leonardo Della Salda
Journal:  Cell Stress Chaperones       Date:  2008-03-12       Impact factor: 3.667

5.  The role of Hsp27 and actin in the regulation of movement in human cancer cells responding to heat shock.

Authors:  Bindi M Doshi; Lawrence E Hightower; Juliet Lee
Journal:  Cell Stress Chaperones       Date:  2009-02-18       Impact factor: 3.667

Review 6.  Role of p38 MAP Kinase Signal Transduction in Solid Tumors.

Authors:  Hari K Koul; Mantu Pal; Sweaty Koul
Journal:  Genes Cancer       Date:  2013-09

7.  A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.

Authors:  Punit Kaur; Ganachari M Nagaraja; Hongying Zheng; Dawit Gizachew; Moses Galukande; Sunil Krishnan; Alexzander Asea
Journal:  BMC Cancer       Date:  2012-03-27       Impact factor: 4.430

8.  Heat shock protein expression in canine malignant mammary tumours.

Authors:  Mariarita Romanucci; Alessia Marinelli; Giuseppe Sarli; Leonardo Della Salda
Journal:  BMC Cancer       Date:  2006-06-27       Impact factor: 4.430

Review 9.  Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer.

Authors:  N S Brown; R Bicknell
Journal:  Breast Cancer Res       Date:  2001-07-23       Impact factor: 6.466

10.  Inhibitors of PI3K/ERK1/2/p38 MAPK Show Preferential Activity Against Endocrine-Resistant Breast Cancer Cells.

Authors:  Maitham A Khajah; Princy M Mathew; Yunus A Luqmani
Journal:  Oncol Res       Date:  2017-03-08       Impact factor: 5.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.